Foamix Pharmaceuticals Ltd. (FOMX) Stock: Great Point Partners Boosts its Stake to 7.57%

Page 4 of 10

Page 4 of 10 – SEC Filing
CUSIP
No. M46135105
13G Page
4 of 9 Pages
1. NAMES OF REPORTING PERSONS
Mr. David Kroin
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY):
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o
3. SEC USE ONLY
4.

CITIZENSHIP OR PLACE OF ORGANIZATION

USA

NUMBER OF SHARES BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
5. SOLE VOTING POWER
0
6. SHARED VOTING POWER
2,769,425
7. SOLE DISPOSITIVE POWER
0
8. SHARED DISPOSITIVE POWER
2,769,425
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
2,769,425
10. CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES
(See Instructions)
o
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
7.57%1
12.

TYPE OF REPORTING PERSON (See Instructions)

IN

Follow Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX)

Page 4 of 10